RecruitingNCT07459582

Accuracy of Home Lactate Meter and Accu-chek Glucometer in Patients With Glycogen Storage Disease

Sponsor

Connecticut Children's Medical Center

Enrollment

10 participants

Start Date

Aug 1, 2026

Study Type

OBSERVATIONAL

Conditions

Glycogen Storage Disease Type Ia Glycogen Storage Disease Type I Glycogen Storage Disease Type IB Glycogen Storage Disease Xi

Summary

The goal of this study is to determine if the Lactate Plus meter is accurate compared to lab lactate levels, and to determine if the Accu chek guide glucometer is accurate compared to lab serum glucose levels in patients with Glycogen Storage Disease Types Ia, Ib and XI. To determine this, patient's will have a one-time planned admission to Connecticut Children's for approximately 8 hours and receive hourly blood draws as well as finger-sticks.

Eligibility

Max Age: 60 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Accu Chek and Lactate Meter for people with glycogen storage disease type i, glycogen storage disease type ib, and other related conditions. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.